General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews

The growing demand for improved pain treatments together with expanding legalization of, and access to, cannabinoids, cannabis, and cannabis-based medicines has intensified the focus on risk–benefit considerations in pain management. Given limited harms data from analgesic clinical trials, we conducted an overview of systematic reviews focused on all harms possibly relevant to patients receiving cannabinoids for pain management. This PROSPERO-registered, PRISMA-compliant systematic overview identified 79 reviews, encompassing over 2200 individual reports about psychiatric and psychosocial harms, cognitive/behavioral effects, motor vehicle accidents, cardiovascular, respiratory, cancer-related, maternal/fetal, and general harms. Reviews, and their included studies, were of variable quality. Available evidence suggests variable associations between cannabis exposure (ranging from monthly to daily use based largely on self-report) and psychosis, motor vehicle accidents, respiratory problems, and other harms. Most evidence comes from settings other than that of pain management (eg, nonmedicinal and experimental) but does signal a need for caution and more robust harms evaluation in future studies. Given partial overlap between patients receiving cannabinoids for pain management and individuals using cannabinoids for other reasons, lessons from the crisis of oversupply and overuse of opioids in some parts of the world emphasize the need to broadly consider harms evidence from real-world settings. The advancement of research on cannabinoid harms will serve to guide optimal approaches to the use of cannabinoids for pain management. In the meantime, this evidence should be carefully examined when making risk–benefit considerations about the use of cannabinoids, cannabis, and cannabis-based medicine for chronic pain.

Click here to read the full article: https://journals.lww.com/pain/Fulltext/2021/07001/General_risks_of_harm_with_cannabinoids,_cannabis,.7.aspx

About IASP
The International Association on the Study of Pain (IASP) is the leading global organization supporting the study and practice of pain and pain relief. IASP brings together scientists, clinicians, health care providers, and policymakers from around the world in pursuit of their mission to bring relief to those who are in pain.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

Marijuana linked to mental health risks in young adults, growing Evidence shows

New research, involving millions of people worldwide over decades, adds to worries that heavy use of high-potency cannabis could exacerbate the mental health crisis in the U.S. “The ideal time to consider using weed — if you’re going to use it — is 26 or later,” said Dr. Ryan Sultan, a psychiatrist at Columbia Irving

Testing the cannabis gateway hypothesis in a national sample of Spanish adolescents

Please cite this article as: A. García-Pérez, G. Aonso-Diego, S. Weidberg, R. Secades-Villa, Testing the cannabisgateway hypothesis in a national sample of Spanish adolescents, Addictive Behaviors Addictive Behaviors (2023),doi: https://doi.org/10.1016/j.addbeh.2023.107751 This article has undergone enhancements after acceptance, such as the addition of a coverpage and metadata, and formatting for readability, but it is not yet

Legalizing Marijuana Is a Big Mistake

Of all the ways to win a culture war, the smoothest is to just make the other side seem hopelessly uncool. So it’s been with the march of marijuana legalization: There have been moral arguments about the excesses of the drug war and medical arguments about the potential benefits of pot, but the vibe of

Marijuana harms development in first trimester of pregnancy, study finds

If you are pregnant and use any form of cannabis product, consider stopping. That’s the takeaway from a new study that found a significant health impact of marijuana use on fetal development as early as the beginning of pregnancy. “That’s why these findings are especially important — people can often be well into the first

IASIC Speaker Series PresentsCannabis Edibles and Pediatric Toxicity

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Scroll to Top